Rocklage Scott M's Form 4 filing
Pear Therapeutics, Inc. (PEAR) · filed Sep 16, 2022
- Accession no.
- 0001209191-22-050387
- Filed
- Sep 16, 2022, 6:03 PM ET
- Trade date
- Sep 14-16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rocklage Scott MCIK 0001219014 | 10% Owner |
| Diekman John DCIK 0001240357 | 10% Owner |
| 5AM Partners IV, LLCCIK 0001589314 | 10% Owner |
| 5AM Ventures IV, L.P.CIK 0001589315 | 10% Owner |
| 5AM Co-Investors IV, L.P.CIK 0001593361 | 10% Owner |
| Schwab Andrew J.CIK 0001598549 | 10% Owner |
| 5AM Opportunities I, L.P.CIK 0001753000 | 10% Owner |
| 5AM Opportunities I (GP), LLCCIK 0001790778 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Class A Common Stock | SSaleDisposed | −273,664 | $1.94 | −$530,908.16 | 13,251,776 | Indirect | |
| Sep 14, 2022 | Class A Common Stock | SSaleDisposed | −11,403 | $1.94 | −$22,121.82 | 552,159 | Indirect | |
| Sep 15, 2022 | Class A Common Stock | SSaleDisposed | −261,840 | $1.81 | −$473,930.4 | 12,989,936 | Indirect | |
| Sep 15, 2022 | Class A Common Stock | SSaleDisposed | −10,910 | $1.81 | −$19,747.1 | 541,249 | Indirect | |
| Sep 16, 2022 | Class A Common Stock | SSaleDisposed | −337 | $1.75 | −$589.75 | 12,989,599 | Indirect | |
| Sep 16, 2022 | Class A Common Stock | SSaleDisposed | −14 | $1.75 | −$24.5 | 541,235 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.